Markus Flepp

8.4k citations
74 papers · 5.6k · 3 hit papers · h-index 33

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • HIV/AIDS drug development and treatment 39
    • HIV/AIDS Research and Interventions 32
    • HIV Research and Treatment 32

Markus Flepp

72 papers receiving 5.3k citations

Markus Flepp's Hit Papers

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study 2000 · 692 citations
6920+9+19Years since publication250500750

Peers

Markus Flepp
Comparison fields: 5 of 128
  • Virology 2.8k
  • Infectious Diseases 4.1k
  • Emergency Medicine 1.0k
  • Hepatology 789
  • Epidemiology 2.0k
Replace Donna Mildvan with:
Donna Mildvan United States
Shinichi Oka Japan
François Raffi France
Jack Fuhrer United States
Gilles Pialoux France
José Ramón Arribas Spain
Harold A. Kessler United States
Gerd Fätkenheuer Germany
Sophie Matheron France
Enrico Girardi Italy
Markus Flepp relative to Donna Mildvan United States Donna Mildvan's profile →
Citations per field
00.5×1.5×
Donna Mildvan · 1×
Citations per year

Countries citing papers authored by Markus Flepp

Since Specialization
Citations

This map shows the geographic impact of Markus Flepp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Flepp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Flepp more than expected).

Fields of papers citing papers by Markus Flepp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Flepp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Flepp. The network helps show where Markus Flepp may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Flepp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Flepp Line = papers co-authored together Markus Flepp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
Hit paper breakdown →
1999772
2
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Hit paper breakdown →
2000692
3
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
Hit paper breakdown →
1997502
4 2012278
5 2001259
6 2000206
7 2008195
8 2001181
9 1999172
10 2001165
11
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study.
1999145
12 1997133
13 2002108
14 1985103
15 198598
16 200390
17 199786
18 200984
19 200468
20 200068

About Markus Flepp

Markus Flepp is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Oncology, having authored 74 papers that have together received 5.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (39 papers), HIV/AIDS Research and Interventions (32 papers), HIV Research and Treatment (32 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV-related health complications and treatments (8 papers), HIV, Drug Use, Sexual Risk (5 papers), Hepatitis C virus research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Virology (2.8k citations), Infectious Diseases (4.1k citations), Emergency Medicine (1.0k citations), Hepatology (789 citations) and Epidemiology (2.0k citations). Markus Flepp has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Pietro Vernazza, Amalio Telenti, Bernard Hirschel, Hansjakob Furrer, P Francioli, Bruno Ledergerber, Martin Rickenbach, Matthias Egger, Philippe Sudre and Rainer Weber. Their work appears in journals such as AIDS, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Antimicrobial Agents and Chemotherapy and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact